Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
-
Biolase (BIOL) Prices $4.5M Preferred Stock and Warrants Offering
-
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH - 22ND
-
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
Biolase (BIOL) Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
Biolase (BIOL) Prices 1.4M Share At-the-market Offering at $4.625/sh
-
BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market
-
BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2022 VIRTUAL GROWTH CONFERENCE HOSTED BY M-VEST ON MARCH 28TH - 30TH
-
BIOLASE To Participate In Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference
-
BIOLASE, Inc. Announces Closing Of $14.4 Million Bought Offering
-
BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering
-
Biolase (BIOL) PT Raised to $2 at Maxim Group, Following Business Update
-
BIOLASE Announces Launch On M-Vest
-
BIOLASE Announces Closing Of Oversubscribed Rights Offering
-
BIOLASE Announces Expiration Of Oversubscribed Rights Offering
-
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020
-
Biolase (BIOL) Announces Commencement of Rights Offering Subscription Period
-
BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period
-
BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
BIOLASE, Inc. Announces Closing of $6.9 Million Registered Direct Offering Priced At-The-Market
-
Biolase (BIOL) Prices $6.9 Million Registered Direct Offering of Common Stock, Warrants
-
BIOLASE, Inc. Announces Pricing of $6.9 Million Registered Direct Offering Priced At-The-Market
